Medicine and Dentistry
Health Care Cost
100%
Maturity Onset Diabetes of the Young
100%
Patient with Type 2 Diabetes
100%
Antidiabetic Agent
100%
Glycon
100%
Sodium Glucose Cotransporter 2 Inhibitor
71%
Sulfonylurea
71%
Quality Adjusted Life Year
57%
Type 2 Diabetes
42%
Cost-Effectiveness Analysis
42%
Dipeptidyl Peptidase-4 Inhibitor
42%
Hemoglobin A1c
28%
Diabetes
14%
Combination Therapy
14%
Meta-Analysis
14%
Glucagon-Like Peptide-1 Agonist
14%
Randomized Clinical Trial
14%
Adverse Drug Reaction
14%
Head
14%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Antidiabetic Agent
100%
Metformin
100%
Sulfonylurea
71%
Sodium Glucose Cotransporter 2 Inhibitor
71%
Dipeptidyl Peptidase IV Inhibitor
42%
Hemoglobin A1c
28%
Adverse Drug Reaction
14%
Glucagon Like Peptide 1 Receptor Agonist
14%
Randomized Clinical Trial
14%
Combination Therapy
14%